Document Detail


A randomized, double-blind, placebo-controlled study of the effect of sustained-release bupropion on blood pressure in individuals with mild untreated hypertension.
MedLine Citation:
PMID:  18480687     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The effects of bupropion on blood pressure and heart rate were evaluated in a double-blind, placebo-controlled study of community volunteers with untreated mild (stage 1) hypertension (systolic blood pressure [SBP], 140-159 mm Hg, and/or diastolic blood pressure, 90-99 mm Hg). Three hundred subjects were randomly assigned (1:1:1:1) to 4 weeks of placebo or bupropion sustained release (SR) 150, 300, or 400 mg/d. Mean clinical blood pressures decreased from baseline to the end of protocol in all groups (n = 296): -6.53, -6.46, -4.20, -4.87 mm Hg for SBP; and -2.36, -2.27, -1.95, -1.55 mm Hg for diastolic blood pressure, for each group, respectively. Although decreases in mean clinical blood pressure were observed in all groups, the reduction in SBP was less on bupropion SR 300 mg/d than on placebo (-4.20 vs -6.53 mm Hg, respectively; Delta = 2.33, P = 0.020). Neither mean 24-hour ambulatory blood pressure measurements nor the proportion of subjects with clinically significant increases in blood pressure differed between any bupropion SR dose and placebo. Mean heart rate increases were small but statistically significant at 400 mg/d versus placebo (2.28 vs -0.64 beats/min; Delta = 2.92, P = 0.004). Although only minor effects on blood pressure were observed in this trial, an infrequent association of bupropion therapy and treatment-emergent hypertension cannot be ruled out.
Authors:
Michael E Thase; Barbara R Haight; Marty C Johnson; Thomas Hunt; Alok Krishen; Richard J Fleck; Jack G Modell
Related Documents :
17086017 - Effects of whey peptides on cardiovascular disease risk factors.
19939607 - Predicting blood pressure response after renal artery stenting.
9220037 - Nifedipine gastrointestinal therapeutic system versus nifedipine coat-core: comparison ...
9622147 - Dose-related efficacy of irbesartan for hypertension: an integrated analysis.
17171947 - Simultaneous measurements of cardiac output by thermodilution, esophageal doppler, and ...
22260457 - Efficacy of aliskiren in japanese chronic kidney disease patients with hypertension.
Publication Detail:
Type:  Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Journal of clinical psychopharmacology     Volume:  28     ISSN:  0271-0749     ISO Abbreviation:  J Clin Psychopharmacol     Publication Date:  2008 Jun 
Date Detail:
Created Date:  2008-05-15     Completed Date:  2008-09-11     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8109496     Medline TA:  J Clin Psychopharmacol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  302-7     Citation Subset:  IM    
Affiliation:
Department of Psychiatry, University of Pennsylvania School of Medicine, 3535 Market Street, Philadelphia, PA 19104, USA. thase@mail.med.upenn.edu
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Antidepressive Agents, Second-Generation / adverse effects*
Blood Pressure / drug effects*
Blood Pressure Monitors
Bupropion / adverse effects*
Delayed-Action Preparations
Dose-Response Relationship, Drug
Double-Blind Method
Drug Administration Schedule
Female
Heart Rate / drug effects
Humans
Hypertension / chemically induced*
Male
Middle Aged
Chemical
Reg. No./Substance:
0/Antidepressive Agents, Second-Generation; 0/Delayed-Action Preparations; 34841-39-9/Bupropion

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Methylphenidate for the treatment of apathy in Alzheimer disease: prediction of response using dextr...
Next Document:  Tiagabine in adult patients with generalized anxiety disorder: results from 3 randomized, double-bli...